IN.PACT Admiral DCB Virtual Reality Experience
“It's exciting to have a non-stented option, because it's cheaper and safer. You guys had already done a great job with the presentation describing this. This just made it that much more exciting. Great demo.”
– Dr. James Harrell, Cardiovascular Surgeon, Covenant Medical Center
The IN.PACT Admiral Drug-Coated Balloon received FDA Approval in the US in January 2015 and received the CE mark in Europe in 2009. Now, patients around the world suffering from peripheral artery disease (PAD) can be treated with the most clinically-effective device available on the market for the treatment of SFA disease.
While you wait to try the virtual reality experience yourself, learn more about the product and how it works by watching our video demo below or downloading our brochures.
To see the leading DCB in virtual reality, find us at an upcoming event or request an on-site demo at your organization.*
For a list of DCB and Virtual Reality FAQs, download this PDF >>
Check back often for ongoing demo updates and device-related news!
* Supplies limited.
Where to Find Us Next
In The Press
Diagnostic and Interventional Cardiology: Medtronic Starts U.S. Launch of In.Pact Admiral Drug-Coated Balloon